Sodium Zirconium Cyclosilicate Patent Expiration
Sodium Zirconium Cyclosilicate is Used for treating hyperkalemia in adults. It was first introduced by Astrazeneca Pharmaceuticals Lp
Sodium Zirconium Cyclosilicate Patents
Given below is the list of patents protecting Sodium Zirconium Cyclosilicate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lokelma | US10300087 | Extended use zirconium silicate compositions and methods of use thereof | Oct 14, 2035 | Astrazeneca |
| Lokelma | US10335432 | Microporous zirconium silicate for the treatment of hyperkalemia | Feb 10, 2032 | Astrazeneca |
| Lokelma | US10398730 | Microporous zirconium silicate for the treatment of hyperkalemia | Feb 10, 2032 | Astrazeneca |
| Lokelma | US10413569 | Microporous zirconium silicate for the treatment of hyperkalemia | Feb 10, 2032 | Astrazeneca |
| Lokelma | US10695365 | Microporous zirconium silicate for the treatment of hyperkalemia | Oct 22, 2033 | Astrazeneca |
| Lokelma | US11406662 | Microporous zirconium silicate for the treatment of hyperkalemia | Feb 10, 2032 | Astrazeneca |
| Lokelma | US11738044 | Extended use zirconium silicate compositions and methods of use thereof | Oct 14, 2035 | Astrazeneca |
| Lokelma | US6332985 | Process for removing toxins from bodily fluids using zirconium or titanium microporous compositions |
Mar 29, 2019
(Expired) | Astrazeneca |
| Lokelma | US8802152 | Microporous zirconium silicate for the treatment of hyperkalemia | Apr 19, 2032 | Astrazeneca |
| Lokelma | US8808750 | Microporous zirconium silicate for the treatment of hyperkalemia | Feb 10, 2032 | Astrazeneca |
| Lokelma | US8877255 | Microporous zirconium silicate for the treatment of hyperkalemia | Oct 22, 2033 | Astrazeneca |
| Lokelma | US9592253 | Extended use zirconium silicate compositions and methods of use thereof | Oct 14, 2035 | Astrazeneca |
| Lokelma | US9844567 | Microporous zirconium silicate for the treatment of hyperkalemia | Feb 10, 2032 | Astrazeneca |
| Lokelma | US9861658 | Microporous zirconium silicate for the treatment of hyperkalemia | Feb 10, 2032 | Astrazeneca |
| Lokelma | US9913860 | Microporous zirconium silicate for the treatment of hyperkalemia | Oct 22, 2033 | Astrazeneca |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳